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Background:  Cardiac Resynchronization Therapy (CRT) improves functional status and reduces heart failure hospitalizations and death in selected 
populations. Improvement in cardiac structure (reverse remodeling) is a marker of CRT response, but the impact of reverse remodeling on long term 
mortality is not well described.
Methods:  REVERSE included 610 NYHA Class I-II patients with QRS≥120 ms and LVEF≤40% who were randomly assigned to either CRT ON 
(n=419) or CRT OFF (n=191) and followed for up to 5 years. LV end-systolic volume index (LVESVi) was measured at baseline and at 6 months by a 
blinded core lab. In the CRT ON group, analysis was performed to determine if a decrease of ≥15% in this prospectively powered reverse remodeling 
endpoint (LVESVi) predicts lower all cause mortality compared to those without significant improvement in LVESVi (< 15%). Survival analysis was 
calculated from 6-month echo assessment to death using Kaplan-Meier methods.
Results:  Of the 353 CRT ON subjects with echo data, 183 (52%) had an improvement in LVESVi. The hazard ratio comparing subjects whose 
6-month LVESVi improved to those whose did not is 0.41 with a 95% confidence interval of 0.19-0.85, p <0.01 (Figure).
Figure 1: Mortality Rate from 6-Month Visit: 6-Month Improvement in LVESVi ≥15% vs. <15%
Conclusion: In the REVERSE study reverse remodeling of a decrease of ≥15% with CRT predicts improved long term survival in mild heart failure. 
